BRYNJELSEN SEAN Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$264,117.86
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of BRYNJELSEN SEAN

According to the SEC Form 4 filings, BRYNJELSEN SEAN, being in a position of

  1. President & CEO at Eton Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 220000 shares for $9.91M,
    over all time since 2018-11-15, has bought 50000 shares for $264,118, and sold 430000 shares for $13.51M.

Biography of BRYNJELSEN SEAN

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$9,913,4903100

Comparison of Insiders on Amount of Buys and Sells

2026-08-20SaleEton Pharmaceuticals, Inc.
ETON
President & CEO
91,022
0.3367%
$60.70$5.53M-7.48%
2026-08-19SaleEton Pharmaceuticals, Inc.
ETON
President & CEO
8,978
0.0334%
$62.65$562,472-9.73%
2026-05-28SaleEton Pharmaceuticals, Inc.
ETON
President & CEO
120,000
0.4384%
$31.88$3.83M+55.84%
2025-06-05SaleEton Pharmaceuticals, Inc.
ETON
President & CEO
70,000
0.2544%
$16.81$1.18M+0.06%
2025-06-04SaleEton Pharmaceuticals, Inc.
ETON
President & CEO
70,000
0.2618%
$17.00$1.19M+1.77%
2025-06-03SaleEton Pharmaceuticals, Inc.
ETON
President & CEO
70,000
0.2645%
$17.51$1.23M-0.17%
2022-09-22PurchaseEton Pharmaceuticals, Inc.
ETON
Chief Executive Officer
10,000
0.0382%
$2.10$21,042+61.06%
2021-08-20PurchaseEton Pharmaceuticals, Inc.
ETON
President & CEO
10,000
0.0388%
$4.32$43,200-12.02%
2021-06-03PurchaseEton Pharmaceuticals, Inc.
ETON
President & CEO
5,000
0.0189%
$5.96$29,800-31.1%
2019-08-13PurchaseEton Pharmaceuticals, Inc.
ETON
President & CEO
5,000
0.029%
$6.15$30,750-1.69%
2019-05-21PurchaseEton Pharmaceuticals, Inc.
ETON
President & CEO
8,600
0.0488%
$7.96$68,431-21.52%
2019-05-20PurchaseEton Pharmaceuticals, Inc.
ETON
President & CEO
1,400
0.0078%
$7.78$10,895-21.72%
2018-11-15PurchaseEton Pharmaceuticals, Inc.
ETON
President & CEO
10,000
0.1545%
$6.00$60,000+7.11%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.